ADVFN ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Nurexone Biologic Inc

Nurexone Biologic Inc (NRX)

0,55
0,00
(0,00%)
Geschlossen 09 Juli 10:00PM

Nurexone Biologic Inc (NRX) Aktie

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Premium

Wichtige Statistiken und Details

Current Price
0,55
( - )
Gebot
0,53
Fragen
0,55
Volumen
-
Durchschnittliches Volumen (3 Mio.)
$ 17.290
Finanzvolumen
-
0,00 Tagesbereich 0,00
0,00 52-Wochen-Bereich 0,00
Marktkapitalisierung
Unternehmenswert
34,593M
Handelsende
0,55
Handelsbeginn
-
Letzte Trade
Letzter Handelszeitpunkt
VWAP
-
Erlöse (LTM)
-
Nettogewinn (LTM)
-6,47M
Ausgegebene Aktien
93.058.421
Streubesitz (%)
94,98%
Institutioneller Besitz (%)
-
Dividendenrendite (LTM)
Kurs-Gewinn-Verhältnis
-5,05
Kurs-Umsatz-Verhältnis (KUV)
-
Gewinn pro Aktie (EPS)
-0,08
Beta
0,38

Über Nurexone Biologic Inc

NurExone Biologic Inc., a pharmaceutical technology company, develops a platform for biologically guided exosome-based therapies for the treatment of central nervous system injuries. It offers ExoPTEN, for treatment of acute spinal cord injuries. The company was founded in 2020 and is based in Toron... NurExone Biologic Inc., a pharmaceutical technology company, develops a platform for biologically guided exosome-based therapies for the treatment of central nervous system injuries. It offers ExoPTEN, for treatment of acute spinal cord injuries. The company was founded in 2020 and is based in Toronto, Canada. Mehr anzeigen

Sektor
Healthcare
Branche
Biotechnology & Life Sciences
Website
Hauptsitz
Toronto, Canada
Gegründet
2026
Nurexone Biologic Inc is listed in the Healthcare sector of the TSX Venture Börse with ticker NRX. The last closing price for Nurexone Biologic was $0,55. Over the last year, Nurexone Biologic shares have traded in a share price range of $ 0,00 to $ 0,00.

Nurexone Biologic currently has 93.058.421 shares in issue. The market capitalisation of Nurexone Biologic is $51,18 million. Nurexone Biologic has a price to earnings ratio (PE ratio) of -5.05.

NRX Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

NRX - Frequently Asked Questions (FAQ)

What is the current Nurexone Biologic Inc share price?
The current share price of Nurexone Biologic Inc is $ 0,55
How many Nurexone Biologic Inc shares are in issue?
Nurexone Biologic Inc has 93.058.421 shares in issue
What is the market cap of Nurexone Biologic Inc?
The market capitalisation of Nurexone Biologic Inc is CAD 51,18M
What is the 1 year trading range for Nurexone Biologic Inc share price?
Nurexone Biologic Inc has traded in the range of $ 0,00 to $ 0,00 during the past year
What is the PE ratio of Nurexone Biologic Inc?
The price to earnings ratio of Nurexone Biologic Inc is -5,05
What is the registered address of Nurexone Biologic Inc?
The registered address for Nurexone Biologic Inc is 1 Adelaide Street East, Toronto, Ontario, M5C 2V9
What is the Nurexone Biologic Inc website address?
The website address for Nurexone Biologic Inc is nurexone.com
Which industry sector does Nurexone Biologic Inc operate in?
Nurexone Biologic Inc operates in the Biotechnology & Life Sciences sector

NRX Trades

Mehr

Trades verzögert

Um Echtzeit-Trades zu erhalten, aktualisieren Sie Ihr Konto

Auf Echtzeit aktualisieren
Keine Diskussionen Gefunden.
Neuen Thread Erstellen